We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Protagen Partners with the National Cancer Institute for Biomarker Research

News   Feb 03, 2017 | Original Story From Protagen

 
Protagen Partners with the National Cancer Institute for Biomarker Research
 
 
 

RELATED ARTICLES

Ovarian Cancer Biomarker Can Predict Patient Therapy Response

News

Researchers have identified an independent prognostic factor - cancer/testis antigen 45 (CT45) - and have begun to elucidate it's actions. CT45 is associated with extended disease-free survival for women with advanced ovarian cancer.

READ MORE

Exposing the Exposome

News

Stanford scientists have measured the human “exposome,” or the particulates, chemicals and microbes that individually swaddle us all, in unprecedented detail.

READ MORE

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

News

Genetic data highlights the previously understated role CD4+ T cells and MHC-II molecules play in keeping cancer at bay.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE